Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
785 participants
OBSERVATIONAL
2024-05-23
2024-09-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low and Moderete Flow Anaesthesia on Haemodynamics
NCT06871371
Low Flow Anesthesia Without Initial High Flow Phase
NCT03955406
Feasibility and Safety Properties of Metabolic Flow Anesthesia Driven by Automated Gas Control in Pediatric Patients
NCT05644340
Low-Flow Anesthesia and Open-Heart Surgery
NCT07040735
Cerebral and Peripheral Near Infrared Spectroscopy Monitoring in Low and High Flow Anaesthesia in Pediatric
NCT06320743
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Inhaler anaesthesia will be administered after anaesthesia induction and tracheal intubation. Fresh gas flow (FGF) will be determined as 1 l/min, MAC=1, FiO2=40% with target controlled automatic gas control mode (AGC). FGF will be decreased to 0.5 l/min 10 minutes after surgical incision, if successful, it will be decreased to 0.3 l/min 10 minutes later and it will be checked whether it is successful. The study will be terminated and FGF will be increased to 1 l/min again.
Demographic data of the patients and FGF levels that can provide FiO2=40% will be recorded.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Previously diagnosed heart, lung, liver and kidney disease
* Surgeries that may impair oxygenation (laparoscopic, Heart, Lung surgeries)
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inonu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yusuf Ziya ÇOLAK
Associate Professor, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yusuf Z Colak, Assoc.Prof.
Role: PRINCIPAL_INVESTIGATOR
Inonu University Anaesthesiology and Reanimation Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Inonu Univercity
Malatya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Inonu LTI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.